Genotyping “Surrogates” Misdiagnoses Deadly Heart Condition

Family members with a certain gene variant had unnecessary interventions, highlighting the potential hazards of precision medicine.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, BRYAN BRANDENBURGAfter a teenage boy died of cardiac arrest, family members underwent genetic testing to see if they had any variants that might predispose them to a similar fate. This so-called surrogate testing—sequencing the genes of relatives—identified what doctors thought was the genetic culprit of the boy’s death, and more than two dozen family members were given a diagnosis of a serious heart condition. But a reanalysis of the family’s genes and heart health, published in Mayo Clinic Proceedings this week (October 31), concludes that they were misdiagnosed, highlighting what the authors consider the “devastating consequences” of surrogate testing.

“This is the proverbial dark side of genetic testing and precision medicine,” paper coauthor Michael Ackerman, a genetic cardiologist at the Mayo Clinic, told STAT News.

Ackerman and colleagues met the family members when they came to the Mayo Clinic for a second opinion. The family members had been diagnosed with long QT (LQT) syndrome, an inherited cardiac disease, based initially on a genetic test given to the brother of the boy who had died. The test showed the brother had a variant in a gene called KCNQ1, and tests of other family members showed they, too, shared the sequence. The brother even received an implanted defibrillator.

But the family members, including the boy’s brother, seemed to have healthy hearts. And when Ackerman sequenced the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies